MARKET

ACHN

Achillion
ACHN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-13.3149
-
4.353
946,715,333.72
News
Financial
Releases
Corp Actions
Analysis
Profile
$930 million sale of Blue Bell biopharma firm finalized
American City Business Journals · 01/29 19:04
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27)
Benzinga · 01/28 14:03
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
Benzinga · 01/28 12:12
Achillion up 16% premarket on advancement of Alexion tie-up
seekingalpha · 01/27 18:16
Agile Awaits PDUFA On Twirla, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 01/27 16:25
Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings?
Zacks · 01/27 15:25
Achillion +15.7% after FTC deal clearance
seekingalpha · 01/25 04:24
Apellis Pharmaceuticals: PEGASUS Trial Confirms Pegcetacoplan's Efficacy Over Soliris In PNH Patients
Seeking Alpha - Article · 01/09 17:46
More
No Data
Learn about the latest financial forecast of ACHN. Analyze the recent business situations of Achillion through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ACHN stock price target is 6.30 with a high estimate of 6.30 and a low estimate of 6.30.
EPS
Institutional Holdings
Institutions: 138
Institutional Holdings: 122.43M
% Owned: 87.42%
Shares Outstanding: 140.05M
TypeInstitutionsShares
Increased
76
-1.66M
New
21
3.79M
Decreased
0
0
Sold Out
13
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.79%
Pharmaceuticals & Medical Research
+0.55%
Key Executives
Chairman/Independent Director
Nicole Vitullo
President/Chief Executive Officer/Director
Joseph Truitt
Chief Financial Officer/Senior Vice President
Brian Di Donato
Chief Operating Officer/Executive Vice President
Paul Firuta
Executive Vice President/General Counsel/Secretary
Martha Manning
Executive Vice President
Anthony Gibney
Vice President/IR Contact Officer
Brian DiDonato
Executive Vice President
Steven Zelenkofske
Vice President - Finance/Controller
Keri Lantz
Independent Director
Jason Fisherman
Independent Director
Kurt Graves
Independent Director
Michael Kishbauch
Independent Director
David Scheer
Independent Director
Robert Van Nostrand
Independent Director
Frank Verwiel
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Achillion stock information, including NASDAQ:ACHN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACHN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACHN stock methods without spending real money on the virtual paper trading platform.